Ting S. Chen
Bethany A. Pfalzgraf
Cravath, Swaine & Moore LLP
Worldwide Plaza
825 Eighth Avenue
New York, NY 10019
+1 (212) 474-1000
|
☐
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
☒ |
|
third-party tender offer subject to Rule 14d-1.
|
|
☐ |
|
issuer tender offer subject to Rule 13e-4.
|
|
☐ |
|
going-private transaction subject to Rule 13e-3.
|
|
☐ |
|
amendment to Schedule 13D under Rule 13d-2.
|
☐ |
|
Rule 13e-4(i) (Cross-Border Issuer Tender Offer)
|
|
☒ |
|
Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)
|
(a) |
The paragraph under the sub-heading “Germany Merger Control Compliance” in Section 17—“Certain Legal Matters; Regulatory Approvals” on page 54 of the Offer to Purchase is amended and supplemented
by adding the following after the last sentence of such paragraph:
|
(b) |
The second paragraph under the sub-heading “Foreign Competition and Investment Laws” in Section 17—“Certain Legal Matters; Regulatory Approvals” on page 55 of the Offer to Purchase is amended and
supplemented by adding the following after the last sentence of such paragraph:
|
(c) |
The information set forth in Section 17—“Certain Legal Matters; Regulatory Approvals” on page 55 of the Offer to Purchase is amended and supplemented by adding the following after the first full
paragraph:
|
Thermo Fisher Scientific Inc.
|
||||
|
By:
|
/s/ Michael A. Boxer
|
||
Name:
|
Michael A. Boxer
|
|||
Title:
|
Senior Vice President and General Counsel
|
|||
Date: |
February 20, 2024 |
Orion Acquisition AB, a direct, wholly owned subsidiary of Thermo Fisher Scientific Inc.
|
||||
|
By:
|
/s/ Anthony H. Smith
|
||
Name:
|
Anthony H. Smith
|
|||
Title:
|
Chairman and Director
|
|||
Date: |
February 20, 2024 |